12:00 AM
 | 
Jun 22, 2009
 |  BioCentury  |  Regulation

Next up in gout

Next up in gout

Company Product Route Description Indication Status for gout
Savient Pharmaceuticals Inc. (NASDAQ:SVNT) Krystexxa pegloticase Intravenous Pegylated urate oxidase (uricase) ...

Read the full 220 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >